European Heart Journal - Cardiovascular Pharmacotherapy

I. Journal Information

II. Scope & Description

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area. While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.

III. Impact Factor History

Note: impact factor data for reference only.

IV. SCImago Journal Rank (SJR)

SJR measures scientific influence, weighting citations by the prestige of the citing journal.

V. H-Index

The H-Index measures both the productivity and citation impact of a journal's publications.

How to Get Published

https://www.editorialmanager.com/ehj-cvp/default.aspx